Testing effectiveness (Phase 2)Study completedNCT00087425
What this trial is testing
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Who this might be right for
LeukemiaLymphoma
National Institute on Aging (NIA) 48